Anika Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Anika Therapeutics Inc
TickerANIK
CIK #0000898437
CUSIP035255108
SectorLife Sciences - Surgical & Medical Instruments & Apparatus
Address236 West Cummings Park, Woburn, MA 01801
Source [EDGAR]
CIK Filing 2011 - 2026
[0000898437] 10-K
[0000898437] 10-Q
[0000898437] 3
[0000898437] 4
[0000898437] 8-K
[0000898437] SC 13D
[0000898437] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Capital Management LLC Anika Therapeutics Inc [2026-04-29] 0.0
BlackRock Portfolio Management LLC Anika Therapeutics Inc [2025-10-17] 0.0
Caligan Partners LP Anika Therapeutics Inc [2023-08-17] 6.2
BlackRock Inc Anika Therapeutics Inc [2023-01-20] 17.3
Trigran Investments Inc Anika Therapeutics Inc [2022-10-07] 10.2
BlackRock Inc Anika Therapeutics Inc [2022-01-26] 16.3
Avidity Partners Management LP Anika Therapeutics Inc [2021-02-16] 5.1
Ameriprise Financial Inc Anika Therapeutics Inc [2021-02-12] 7.07
Renaissance Technologies LLC Anika Therapeutics Inc [2021-02-10] 5.69
State Street Corp Anika Therapeutics Inc [2021-02-05] 5.77
State Street Corp Anika Therapeutics Inc [2020-02-13] 6.03
Kayne Anderson Rudnick Investment Management LLC Anika Therapeutics Inc [2017-08-08] 11.49
Vanguard Group Inc Anika Therapeutics Inc [2017-02-09] 5.77
Thompson Siegel & Walmsley LLC Anika Therapeutics Inc [2016-01-28] 11.0
Wellington Management Group LLP Anika Therapeutics Inc [2015-02-12] 5.79
BlackRock Inc Anika Therapeutics Inc [2014-01-28] 8.1
Dimensional Fund Advisors LP Anika Therapeutics Inc [2013-02-11] 6.13
Dimensional Fund Advisors LP Anika Therapeutics Inc [2012-02-14] 6.11
Form 3/4/5 Filer 2011 - 2026
Fischetti Gary P
Anika Therapeutics Inc
Conley Sheryl L
Capper Joseph H
Richard Stephen
Henneman John B III
Griffin Stephen D
McLeod Ian
Blanchard Cheryl R
Colleran David
VOGT Susan L N
Larsen Glenn R
Jellison William R
Nunes Anne
Levitz Michael L
Thompson Jeffery S
Finnerty Thomas
Loerop James
Land Raymond J
Bower Joseph I
Cheung Sylvia
Darling Joseph G
Ahn Edward S
Hague Richard
Sherwood Charles H
Wheeler Steve E
Alexander Dana M
Mascioli Stephen R
Moran John C
Luppino Francesco J
Barnett Carol A
Sheets John W Jr
Fidia Farmaceutici SpA
Quinlan Kevin W
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
McLeod Ian
Restricted Stock Unit · derivative
2026-03-19 Grant 13,097 $0.00
McLeod Ian
Restricted Stock Unit · derivative
2026-03-19 Grant 11,194 $0.00
McLeod Ian
Premium Priced Stock Appreciation Rights · derivative
2026-03-19 Grant 17,663 $0.00
Blanchard Cheryl R
Common Stock
2026-03-15 Option exercise 25,131
Blanchard Cheryl R
Restricted Stock Unit · derivative
2026-03-15 Option exercise 25,131 $0.00
Colleran David
Restricted Stock Unit · derivative
2026-03-15 Option exercise 6,449 $0.00
McLeod Ian
Common Stock
2026-03-15 Tax withheld 781 $14.20 11,090
Colleran David
Common Stock
2026-03-15 Option exercise 6,449
Colleran David
Common Stock
2026-03-15 Tax withheld 1,893 $14.20 26,881
McLeod Ian
Restricted Stock Unit · derivative
2026-03-15 Option exercise 2,658 $0.00
Blanchard Cheryl R
Common Stock
2026-03-15 Tax withheld 12,104 $14.20 171,877
McLeod Ian
Common Stock
2026-03-15 Option exercise 2,658
McLeod Ian
Common Stock
2026-03-14 Option exercise 3,774
Blanchard Cheryl R
Common Stock
2026-03-14 Tax withheld 14,728 $14.20 209,138
Colleran David
Common Stock
2026-03-14 Option exercise 9,388
Griffin Stephen D
Restricted Stock Unit · derivative
2026-03-14 Option exercise 12,824 $0.00
Colleran David
Common Stock
2026-03-14 Grant 4,694 $0.00
McLeod Ian
Common Stock
2026-03-14 Tax withheld 1,449 $14.20 20,576
Griffin Stephen D
Common Stock
2026-03-14 Tax withheld 5,944 $14.20 84,405
McLeod Ian
Restricted Stock Unit · derivative
2026-03-14 Option exercise 3,774 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 130 11,768,050
2025-12-31 126 11,691,388
2025-09-30 117 11,619,013
2025-06-30 105 12,135,541
2025-03-31 109 12,141,348
2024-12-31 110 12,086,256
2024-09-30 123 12,651,882
2024-06-30 115 12,830,129
2024-03-31 121 14,426,440
2023-12-31 118 13,394,231
2023-09-30 117 12,535,589
2023-06-30 118 13,019,936
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 63,016 63,016
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 409 15,577
Versant Capital Management Inc [2026-06-30] SOLE 3,733 3,733
Curated Wealth Partners LLC [2026-06-30] OTR 0 830
Gamma Investing LLC [2026-06-30] DFND 320 320
IFP Advisors LLC [2026-06-30] SOLE 289 289
Farther Finance Advisors LLC [2026-06-30] SOLE 0 213
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 159 159
True Wealth Design LLC [2026-06-30] SOLE 0 142
GHP Investment Advisors Inc [2026-06-30] SOLE 44 44
Fortitude Family Office LLC [2026-06-30] SOLE 18 18
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com